Skip to main content
. 2020 Jun 10;7:99. doi: 10.3389/fcvm.2020.00099

Table 2.

Pressure and volume measurements.

Timepoint Baseline Pre-onset of Onset of During reperfusion End of experiment p-value time*device
(t-60) MCS (t-20) MCS (t5) (t40) (t150) (device)
Parameter Device
mAOP (mmHg) Impella 65.8 ± 13.04 68.60 ± 12.47 73.6 ± 15.73 75.4 ± 14.88 70.8 ± 16.31 0.663 (0.335)
ECMO 58.4 ± 3.07 51.20 ± 5.15 64.4 ± 15.86 67.4 ± 17.76 61.8 ± 5.04
CVP (mmHg) Impella 3 ± 2.1 4.40 ± 3.83 2.6 ± 2.73 3.2 ± 3.12 2.2 ± 2.48 0.082 (0.644)
ECMO 2.2 ± 1.94 2.80 ± 2.48 0.4 ± 2.73 0.2 ± 2.04 1.4 ± 1.85
mPAP (mmHg) Impella 18.4 ± 1.36 23.20 ± 10.61 19.4 ± 5.61 21 ± 6.2 19.2 ± 4.02 0.005 (0.001)
ECMO 17.2 ± 4.07 15.80 ± 3.71 11.2 ± 3.6 7.8 ± 1.6 6.6 ± 1.96
SV (ml) Impella 71 (24) 16 (24) 25 (19) 22 (34) 33 ± 24.22 0.003 (0.124)
ECMO 80 (20) 66 (23) 41 (9) 33 (15) 33 ± 9.49

mAO, mean aortic pressure; CVP, central venous pressure; mPAP, mean pulmonary artery pressure.